独立董事候选人声明与承诺 本人关忠良，已充分了解并同意由提名人柳州两面针股份有 限公司董事会提名为柳州两面针股份有限公司第九届董事会独 立董事候选人。本人公开声明，本人具备独立董事任职资格，保 证不存在任何影响本人担任柳州两面针股份有限公司独立董事 独立性的关系，具体声明并承诺如下： 一、本人具备上市公司运作的基本知识，熟悉相关法律、行 政法规、部门规章及其他规范性文件，具有 20 年以上法律、经 济、会计、财务、管理或者其他履行独立董事职责所必需的工作 经验。 （五）中共中央组织部《关于进一步规范党政领导干部在企 业兼职（任职）问题的意见》的相关规定（如适用）； 1 （六）中共中央纪委、教育部、监察部《关于加强高等学校 反腐倡廉建设的意见》的相关规定（如适用）； （七）中国人民银行《股份制商业银行独立董事和外部监事 制度指引》等的相关规定（如适用）； 本人已经参加培训并取得证券交易所认可的相关培训证明 材料。 二、本人任职资格符合下列法律、行政法规和部门规章以及 公司规章的要求： （一）《中华人民共和国公司法》关于董事任职资格的规定； （二）《中华人民共和国公务员法》关于公务员兼任职务的 规定（如适用）； ...

证券代码：600249 证券简称：两面针 公告编号：2026-003 柳州两面针股份有限公司 关于召开2026年第一次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一) 股东会类型和届次 2026年第一次临时股东会 (二) 股东会召集人：董事会 (三) 投票方式：本次股东会所采用的表决方式是现场投票和网络投 票相结合的方式 (四) 现场会议召开的日期、时间和地点 召开的日期时间：2026 年 2 月 3 日 9 点 30 分 召开地点：广西柳州市东环大道 282 号本公司五楼会议室 (五) 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东会网络投票系统 股东会召开日期：2026年2月3日 本次股东会采用的网络投票系统：上海证券交易所股东会网络投票 系统 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票 时间为股东会召开当日的交易时间段，即 9:15-9:25，9:30-11:30， 13:00-15:00；通过互联网投票平台的投票时 ...

证券代码：600249 证券简称：两面针 公告编号：临2026-001 柳州两面针股份有限公司 第八届董事会第三十三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、董事会会议召开情况 柳州两面针股份有限公司（以下简称"公司"）第八届董事会第三十三次 会议于 2026 年 1 月 15 日以通讯方式召开，会议通知于 2026 年 1 月 12 日 以专人送达、电子邮件方式发出。本次会议应表决董事七名，实际表决董 事七名，分别为：周云祥先生、龚慧泉先生、孙雪东先生、唐鹏先生、张 重义先生、余兵先生、魏佳先生。会议召开符合《公司法》《公司章程》 和《公司董事会议事规则》的有关规定。 二、董事会会议审议情况 （一）审议通过了《关于提名公司第九届董事会非独立董事候选人的 议案》； （二）审议通过了《关于提名公司第九届董事会独立董事候选人的议 案》； 1 同意提名关忠良先生、刘婷婷女士、杨修先生为公司第九届董事会独 立董事候选人，任期自公司股东会审议通过之日起三年。详见公司同期披 露的《两面针关于董事会换届选举的 ...

Core Viewpoint - The personal care products sector experienced a decline of 1.72% on January 15, with a notable drop in the stock of Wanjian Medical, while the overall market showed mixed results with the Shanghai Composite Index down 0.33% and the Shenzhen Component Index up 0.41% [1] Group 1: Market Performance - The personal care products sector's decline was led by Wanjian Medical, which fell by 3.57% to a closing price of 38.08 [2] - The Shanghai Composite Index closed at 4112.6, down 0.33%, while the Shenzhen Component Index closed at 14306.73, up 0.41% [1] Group 2: Individual Stock Performance - Notable stock performances included: - Dengkang Oral (001328) rose by 2.51% to 41.27 with a trading volume of 28,300 shares and a transaction value of 116 million [1] - Other stocks such as Zhongshun Jierou (002511) and Liangmian Needle (600249) saw minor declines of 0.24% and 0.51% respectively [1] - The largest decline was observed in Wanjian Medical (300888), which dropped by 3.57% [2] Group 3: Capital Flow - The personal care products sector saw a net inflow of 531,700 yuan from institutional investors, while retail investors experienced a net outflow of 2,407,430 yuan [2] - The capital flow for individual stocks indicated that Wanjian Medical had a net inflow of 21,931,300 yuan from institutional investors, but a significant outflow of 45,204,800 yuan from retail investors [3]

Core Viewpoint - The personal care products sector experienced a slight increase of 0.2% on January 14, with Baiya Co., Ltd. leading the gains, while the Shanghai Composite Index fell by 0.31% and the Shenzhen Component Index rose by 0.56% [1]. Group 1: Market Performance - The closing price of Baiya Co., Ltd. was 21.24, with an increase of 1.09% and a trading volume of 77,000 shares, amounting to a transaction value of 163 million yuan [1]. - Other notable performers included Yiyi Co., Ltd. with a closing price of 28.72 and a rise of 1.06%, and Haoyue Care with a closing price of 32.78 and an increase of 1.02% [1]. - Conversely, companies like Jiya Co., Ltd. and Wanjian Medical saw slight declines of 0.19% and 0.23%, respectively [1]. Group 2: Capital Flow - The personal care products sector saw a net inflow of 4.32 million yuan from institutional investors, while retail investors experienced a net outflow of 7.12 million yuan [2]. - The capital flow data indicates that Yiyi Co., Ltd. had a significant net inflow of 13.31 million yuan from institutional investors, while it faced a net outflow of 6.19 million yuan from retail investors [3]. - Other companies like Haoyue Care and Dongkang Oral also showed mixed capital flows, with institutional inflows but retail outflows [3].

Market Overview - The personal care products sector experienced a slight decline of 0.03% on January 13, with Baiya Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 4138.76, down 0.64%, while the Shenzhen Component Index closed at 14169.4, down 1.37% [1] Stock Performance - Notable gainers in the personal care sector included: - Dengkang Oral Care (001328) with a closing price of 40.60, up 6.17% [1] - Beijia Clean (603059) with a closing price of 36.25, up 3.93% [1] - Jieya Co., Ltd. (301108) with a closing price of 35.95, up 3.72% [1] - Other stocks showed mixed performance, with some experiencing declines, such as: - Two-Sided Needle (600249) down 0.67% to 5.92 [1] - Zhongshun Jiesang (002511) down 0.95% to 8.32 [1] Capital Flow - The personal care products sector saw a net inflow of 17.19 million yuan from institutional investors, while retail investors experienced a net outflow of 20.21 million yuan [2] - The capital flow for individual stocks indicated that: - Reliable Co., Ltd. (301009) had a net inflow of 10.73 million yuan from institutional investors [3] - Beijia Clean (603059) faced a net outflow of 3.99 million yuan from institutional investors [3]

Market Overview - The personal care products sector increased by 1.28% on January 12, with Beijia leading the gains [1] - The Shanghai Composite Index closed at 4165.29, up by 1.09%, while the Shenzhen Component Index closed at 14366.91, up by 1.75% [1] Stock Performance - Beijia (603059) closed at 34.88, with a rise of 10.00% and a trading volume of 21,500 lots, resulting in a transaction value of 74.26 million yuan [1] - Haoyue Care (605009) closed at 32.52, up by 2.59%, with a trading volume of 38,600 lots and a transaction value of 124 million yuan [1] - Reliable Co. (301009) closed at 13.11, increasing by 1.55%, with a trading volume of 47,100 lots and a transaction value of 61.36 million yuan [1] - Other notable stocks include: - Wenjian Medical (300888) at 39.73, up by 1.43% [1] - Runben Co. (603193) at 25.33, up by 1.40% [1] - Liangmian Needle (600249) at 5.96, up by 1.36% [1] Capital Flow - The personal care products sector experienced a net outflow of 1.1334 million yuan from institutional investors, while retail investors saw a net inflow of 5.4803 million yuan [2] - The overall capital flow indicates that while institutional investors withdrew funds, retail investors were actively buying into the sector [2] Detailed Capital Flow Analysis - Beijia (603059) had a net inflow of 23.84 million yuan from institutional investors, but a net outflow of 9.50 million yuan from speculative funds [3] - Haoyue Care (605009) saw a net inflow of 18.45 million yuan from institutional investors, with a net outflow of 12.29 million yuan from speculative funds [3] - Reliable Co. (301009) experienced a net outflow of 5.92 million yuan from institutional investors, while retail investors contributed a net inflow of 6.46 million yuan [3]

Market Overview - The personal care products sector increased by 0.64% on January 9, with Dengkang Oral leading the gains [1] - The Shanghai Composite Index closed at 4120.43, up 0.92%, while the Shenzhen Component Index closed at 14120.15, up 1.15% [1] Stock Performance - Key stocks in the personal care sector showed varied performance, with Dengkang Oral closing at 39.19, up 1.79% on a trading volume of 15,000 shares and a transaction value of 58.84 million yuan [1] - Other notable performers included: - Zhongshun Jierou at 8.38, up 1.09%, with a trading volume of 164,500 shares and a transaction value of 137 million yuan [1] - Wanjian Medical at 39.17, up 1.03%, with a transaction value of 166 million yuan [1] - Liangmian Needle at 5.88, up 1.03%, with a trading volume of 119,500 shares and a transaction value of 69.76 million yuan [1] Capital Flow - The personal care products sector experienced a net outflow of 9.1265 million yuan from institutional investors and 14.5833 million yuan from speculative funds, while retail investors saw a net inflow of 23.7098 million yuan [2] - Detailed capital flow for specific stocks included: - Runben Co. with a net inflow of 4.5229 million yuan from institutional investors, but a net outflow of 6.0816 million yuan from speculative funds [3] - Yiyi Co. had a net outflow of 51,000 yuan from institutional investors, but a net inflow of 619.27 million yuan from retail investors [3] - Dengkang Oral saw a net outflow of 1.5334 million yuan from institutional investors [3]

Core Viewpoint - The company emphasizes the significance of Chlorinated Two-Needle Alkaloid as the main active ingredient in its traditional Chinese medicine products, highlighting ongoing research and development efforts to enhance its applications and extraction processes [1] Group 1: Research and Development - The company has established a post-doctoral research workstation dedicated to the systematic study of the medicinal components and extraction techniques of Two-Needle medicine [1] - Continuous research efforts are aimed at providing technical support for the scientific and rational development and utilization of Two-Needle medicine [1] Group 2: Product Application - Chlorinated Two-Needle Alkaloid is widely used in the majority of the company's toothpaste products, serving as a core quality control indicator [1] - The inclusion of this active ingredient ensures the stable efficacy of Two-Needle medicine toothpaste, providing reliable assurance for product quality [1]

Core Viewpoint - The company is expanding its overseas business through various cross-border platforms while maintaining its traditional market channels to enhance profitability [1] Group 1: Overseas Business Expansion - The company is leveraging platforms such as Alibaba International Station, China Manufacturing Network, Lazada, Shopee, and TikTok to broaden its international business [1] Group 2: Traditional Market Strategy - The company aims to stabilize and deepen value in existing markets, thereby consolidating its foundational business [1] - The company is activating market potential through strategic efforts in traditional channels [1] Group 3: Product Innovation - The company is attempting to drive profit growth through the introduction of new products [1]